Form D · Other Health Care
Avertix Medical, Inc.
Eatontown, NJ · CIK 0001564031
Offering snapshot reported Sep 23, 2025 · SEC filing
- Reported sold
- $1.01M Offering amount: $5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2025 | Initial | $1,011,667 | No comparison | 4 | SEC filing |
| Mar 11, 2025 | Amendment | $14,253,772 | $7,495,899vs Sep 9, 2024 | 40 | SEC filing |
| Sep 9, 2024 | Initial | $6,757,873 | No comparison | 8 | SEC filing |
| Aug 14, 2024 | Initial | $7,092,079 | No comparison | 59 | SEC filing |
| May 10, 2024 | Amendment | $13,480,307 | $6,691,544vs Nov 13, 2023 | 53 | SEC filing |
| Nov 13, 2023 | Initial | $6,788,763 | No comparison | 39 | SEC filing |
| Mar 1, 2023 | Initial | $34,252,457 | No comparison | 82 | SEC filing |
| Sep 6, 2022 | Initial | $6,000,000 | No comparison | 20 | SEC filing |
| Aug 17, 2021 | Initial | $3,857,162 | No comparison | 39 | SEC filing |
| Apr 1, 2019 | Initial | $10,000,000 | No comparison | 56 | SEC filing |
| Jan 17, 2019 | Initial | $600,000 | No comparison | 2 | SEC filing |
| Dec 8, 2014 | Initial | $10,215,000 | No comparison | 22 | SEC filing |
| Dec 16, 2013 | Amendment | $20,531,000 | $2,996,000vs Apr 3, 2013 | 23 | SEC filing |
| Apr 3, 2013 | Amendment | $17,535,000 | $13,772,500vs Dec 13, 2012 | 19 | SEC filing |
| Dec 13, 2012 | Initial | $3,762,500 | No comparison | 17 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-558351
Total offering amount does not include up to $1,250,000 that may be received upon issuance of warrants already issued and that may be issued in the future to purchase preferred stock.
Source: Form D, filed Sep 23, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Taylor Andrew | Director |
| Joseph Berardo | Director |
| Sean Cullinan | Director |
| Eric Fain | Director |
| David Fischell | Director |
| Robert Fischell | Director |
| Frank Fischer | Director |
| Robert J. Flanagan | Director |
| Ross Haghighat | Director, Executive |
| Steven R. Johnson | Executive |
| Kadir Kadhiresan | Director |
| Dave Keenan | Executive |
| David Keenan | Executive |
| Tom Mendell | Director |
| Timothy P. Moran | Director, Executive |
| Benjamin Pless | Director |
| Ben Pless | Director |
| Christopher Pucillo | Director |
| Haghighat Ross | Director |
| Richard Schatz | Director |
| Brad Snow | Director, Executive |
| Andrew Taylor | Director |
| Phillip L. Tom | Executive |
| Mendell Tom | Director |
| Phillip D Torrence | Executive |
| Victor Whitman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
40 Christopher Way Suite 201
Eatontown, NJ, 07724
Eatontown, NJ, 07724